Page 17 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

List of Contributors xv

Gene G. Hunder, M.D.
Emeritus Staff Center
Mayo Clinic
200 First St SW
Rochester, Minnesota, USA
Primary CNS Vasculitis: Pathophysiological Diversity (Chapter 25)

David R. W. Jayne, M.D.
Addenbrooke?s Hospital
Cambridge University Hospitals
University of Cambridge School of Clinical Medicine
National Health Service Foundation Trust
Cambridge, United Kingdom
Future Directions of Therapeutic Trials (Chapter 33)

J. Charles Jennette, M.D.
Department of Pathology and Laboratory Medicine
University of North Carolina Kidney Center
Chapel Hill, North Carolina, USA
Nomenclature and Pathologic Features of Vasculitides (Chapter 6)
Systemic Vasculitis and the Kidney: ANCA Vasculitis and Glomerulonephritis (Chapter 13)

Adam Kirton, M.D., M.Sc.
Department of Pediatrics, Section of Neurology
Alberta Children?s Hospital Research Institute
Calgary, Alberta, Canada
Childhood Vasculitic Stroke (Chapter 24)

John Kirwan, B.Sc., M.B., B.S (London)
Academic Rheumatology Unit
Bristol Royal Infirmary
Bristol BS2 8HW, United Kingdom
Giant Cell Arteritis (Chapter 17)

Lindsay Lally, M.D.
Division of Rheumatology
Hospital for Special Surgery
New York, New York, USA
Clinical Approach to Patients with Vasculitis (Chapter 9)

Mark A. Little, F.R.C.P., Ph.D.
UCL Centre for Nephrology
London and Trinity Health Kidney Centre
Trinity College, Dublin, Ireland
Experimental Autoimmune Vasculitis: Insights into Human Vasculitis Using Animal Models
(Chapter 4)

Complimentary Contributor Copy